Stay updated on Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma
Sign up to get notified when there's something new on the Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma page.

Latest updates to the Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma page
- CheckyesterdayNo Change Detected
- Check8 days agoNo Change Detected
- Check15 days agoChange DetectedThe page history now includes a new revision entry labeled v3.7.0, and the previous revision v3.6.6 was removed from the history.SummaryDifference0.1%

- Check36 days agoChange DetectedThe study record history now includes a new revision entry v3.6.6, updating the page to the latest release. The prior revision v3.6.5 is superseded in the history.SummaryDifference0.1%

- Check58 days agoChange DetectedThe study record history shows a new revision entry (v3.6.5) added and the previous revision (v3.6.4) removed, indicating a small platform update to the page.SummaryDifference0.1%

- Check72 days agoChange DetectedA new revision entry v3.6.4 was added to the study record history, replacing the prior v3.6.3; this reflects an updated release note for the page.SummaryDifference0.1%

- Check93 days agoChange DetectedThe study record history shows a new revision v3.6.3 replacing v3.6.2, indicating a small administrative update to the page's versioning.SummaryDifference0.1%

- Check100 days agoChange DetectedA new revision entry (v3.6.2) was added to the study record history, and the previous revision (v3.6.0) was removed from the visible history. This reflects an administrative update to the version history rather than changes to study content.SummaryDifference0.1%

Stay in the know with updates to Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma
Enter your email address, and we'll notify you when there's something new on the Clinical Trial: Ixazomib Combo in Relapsed Multiple Myeloma page.